CytoMed Therapeutics Limited (GDTC)
NASDAQ: GDTC · Real-Time Price · USD
1.770
-0.080 (-4.32%)
Dec 5, 2025, 4:00 PM EST - Market closed
CytoMed Therapeutics Cash Flow Statement
Financials in millions SGD. Fiscal year is January - December.
Millions SGD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
| Net Income | -3.67 | -2.52 | -4.13 | -3.13 | -2.05 | -1.94 | Upgrade
|
| Depreciation & Amortization | 0.35 | 0.33 | 0.38 | 0.39 | 0.33 | 0.29 | Upgrade
|
| Other Amortization | 0 | 0 | 0 | - | 0 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0 | - | - | -0 | - | - | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.01 | - | - | 0 | - | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.01 | -0.01 | 0.03 | 0.03 | 0.21 | - | Upgrade
|
| Other Operating Activities | -0.23 | -0.45 | 0.08 | 1.2 | 0.17 | 0.68 | Upgrade
|
| Change in Accounts Receivable | -0.3 | -0.08 | -0.01 | -0.15 | -0.43 | -0.16 | Upgrade
|
| Change in Accounts Payable | 0.17 | -0.08 | 0.11 | 0.27 | 0.06 | 0.28 | Upgrade
|
| Change in Unearned Revenue | 0.07 | 0.1 | 0 | -0.01 | - | - | Upgrade
|
| Operating Cash Flow | -3.15 | -2.71 | -3.53 | -1.4 | -1.71 | -0.85 | Upgrade
|
| Capital Expenditures | -0.84 | -1.4 | -0.06 | -0.47 | -0.58 | -0.24 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | - | - | 0 | - | - | Upgrade
|
| Divestitures | 0.16 | 0.16 | - | - | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.09 | -0.09 | - | - | - | -0.02 | Upgrade
|
| Investment in Securities | 3.23 | 2.5 | -2.77 | - | -0.24 | -0.25 | Upgrade
|
| Other Investing Activities | 0.54 | 0.47 | 0.1 | - | - | - | Upgrade
|
| Investing Cash Flow | 2.99 | 1.13 | -2.73 | -0.47 | -0.82 | -0.51 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 0.3 | 0.35 | 1.5 | Upgrade
|
| Total Debt Issued | - | - | - | 0.3 | 0.35 | 1.5 | Upgrade
|
| Short-Term Debt Repaid | - | - | -0.3 | -0.35 | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -0.04 | -0.04 | -0.08 | -0.06 | -0.01 | Upgrade
|
| Total Debt Repaid | -0.05 | -0.04 | -0.34 | -0.43 | -0.06 | -0.01 | Upgrade
|
| Net Debt Issued (Repaid) | -0.05 | -0.04 | -0.34 | -0.13 | 0.29 | 1.49 | Upgrade
|
| Issuance of Common Stock | - | - | 11.31 | 1.22 | 4 | 0.5 | Upgrade
|
| Other Financing Activities | -0.02 | -0.02 | -0.05 | -0.13 | -0.12 | -0.11 | Upgrade
|
| Financing Cash Flow | -0.07 | -0.06 | 10.92 | 0.97 | 4.17 | 1.88 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.14 | 0.12 | -0.01 | -0.03 | -0.01 | -0.01 | Upgrade
|
| Net Cash Flow | -0.37 | -1.53 | 4.64 | -0.93 | 1.63 | 0.51 | Upgrade
|
| Free Cash Flow | -3.99 | -4.11 | -3.59 | -1.87 | -2.3 | -1.09 | Upgrade
|
| Free Cash Flow Margin | -546.82% | -816.52% | -706.96% | -514.47% | -2016.27% | -1839.93% | Upgrade
|
| Free Cash Flow Per Share | -0.35 | -0.36 | -0.34 | -0.24 | -0.33 | -0.19 | Upgrade
|
| Cash Interest Paid | 0.02 | 0.02 | 0.05 | 0.13 | 0.12 | 0.11 | Upgrade
|
| Cash Income Tax Paid | - | - | 0 | - | - | - | Upgrade
|
| Levered Free Cash Flow | -2.37 | -3.17 | -2.04 | -1.29 | -1.75 | -1.28 | Upgrade
|
| Unlevered Free Cash Flow | -2.36 | -3.16 | -2.01 | -1.21 | -1.68 | -1.22 | Upgrade
|
| Change in Working Capital | -0.06 | -0.06 | 0.1 | 0.11 | -0.37 | 0.12 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.